ABP 206
20210031
Phase 3 small_molecule active
Quick answer
ABP 206 for Melanoma is a Phase 3 program (small_molecule) at Amgen with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen
- Indication
- Melanoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active